Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy

Kyoko Fujita,1 Kei Shinoda,1,2 Celso Soiti Matsumoto,2 Yutaka Imamura,3 Etsuko Tanaka,4 Yoshihiro Mizutani,1 Atsushi Mizota,2 Mitsuko Yuzawa11Department of Ophthalmology, Surugadai Nihon University Hospital, Tokyo, 2Teikyo University School of Medicine, University Hospital Itabashi, Tokyo, 3Teikyo U...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fujita K, Shinoda K, Matsumoto CS, Imamura Y, Tanaka E, Mizutani Y, Mizota A, Yuzawa M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/eb8218f287364e40b92ac1de0d3b393b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:eb8218f287364e40b92ac1de0d3b393b
record_format	dspace
spelling	oai:doaj.org-article:eb8218f287364e40b92ac1de0d3b393b2021-12-02T03:56:20ZMicroperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy1177-54671177-5483https://doaj.org/article/eb8218f287364e40b92ac1de0d3b393b2012-10-01T00:00:00Zhttp://www.dovepress.com/microperimetric-evaluation-of-chronic-central-serous-chorioretinopathy-a11279https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Kyoko Fujita,1 Kei Shinoda,1,2 Celso Soiti Matsumoto,2 Yutaka Imamura,3 Etsuko Tanaka,4 Yoshihiro Mizutani,1 Atsushi Mizota,2 Mitsuko Yuzawa11Department of Ophthalmology, Surugadai Nihon University Hospital, Tokyo, 2Teikyo University School of Medicine, University Hospital Itabashi, Tokyo, 3Teikyo University School of Medicine, University Hospital Mizonokuchi, Kanagawa, 4Kyorin University School of Medicine, Mitaka, JapanBackground: The purpose of this study was to determine baseline clinical factors to correlate the outcome of half-dose verteporfin photodynamic therapy (PDT) in eyes with chronic central serous chorioretinopathy (CSC).Methods: In this prospective, non-comparative, interventional case series, 14 eyes of 14 patients with chronic CSC who received half-dose verteporfin PDT were examined. The best-corrected visual acuity (BCVA), macular sensitivity in the central 4, 8, and 12 degrees, and fixation stability were evaluated at baseline and at months 1, 3, 6, and 12 after half-dose verteporfin PDT. Macular sensitivity and fixation stability were determined by MP-1 microperimetry.Results: Mean retinal sensitivity in the central 4 and 8 degrees was significantly better at 1, 3, 6, and 12 months after half-dose verteporfin PDT than at baseline. BCVA was significantly better after half-dose verteporfin PDT but only after 3 months. Fixation was relatively unstable in three eyes at baseline, but became stable at 12 months. BCVA at 12 months was significantly correlated with pre-PDT fixation stability (r = 0.7120, P = 0.0038).Conclusion: Half-dose verteporfin PDT results in a significant increase in mean central retinal sensitivity for at least 12 months. Our findings indicate that microperimetry is a useful method for evaluating the functional benefits of half-dose verteporfin PDT in eyes with chronic CSC.Keywords: microperimetry, fixation point, retinal sensitivity, photodynamic therapy, chronic central serous chorioretinopathyFujita KShinoda KMatsumoto CSImamura YTanaka EMizutani YMizota AYuzawa MDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2012, Iss default, Pp 1681-1687 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Fujita K Shinoda K Matsumoto CS Imamura Y Tanaka E Mizutani Y Mizota A Yuzawa M Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
description	Kyoko Fujita,1 Kei Shinoda,1,2 Celso Soiti Matsumoto,2 Yutaka Imamura,3 Etsuko Tanaka,4 Yoshihiro Mizutani,1 Atsushi Mizota,2 Mitsuko Yuzawa11Department of Ophthalmology, Surugadai Nihon University Hospital, Tokyo, 2Teikyo University School of Medicine, University Hospital Itabashi, Tokyo, 3Teikyo University School of Medicine, University Hospital Mizonokuchi, Kanagawa, 4Kyorin University School of Medicine, Mitaka, JapanBackground: The purpose of this study was to determine baseline clinical factors to correlate the outcome of half-dose verteporfin photodynamic therapy (PDT) in eyes with chronic central serous chorioretinopathy (CSC).Methods: In this prospective, non-comparative, interventional case series, 14 eyes of 14 patients with chronic CSC who received half-dose verteporfin PDT were examined. The best-corrected visual acuity (BCVA), macular sensitivity in the central 4, 8, and 12 degrees, and fixation stability were evaluated at baseline and at months 1, 3, 6, and 12 after half-dose verteporfin PDT. Macular sensitivity and fixation stability were determined by MP-1 microperimetry.Results: Mean retinal sensitivity in the central 4 and 8 degrees was significantly better at 1, 3, 6, and 12 months after half-dose verteporfin PDT than at baseline. BCVA was significantly better after half-dose verteporfin PDT but only after 3 months. Fixation was relatively unstable in three eyes at baseline, but became stable at 12 months. BCVA at 12 months was significantly correlated with pre-PDT fixation stability (r = 0.7120, P = 0.0038).Conclusion: Half-dose verteporfin PDT results in a significant increase in mean central retinal sensitivity for at least 12 months. Our findings indicate that microperimetry is a useful method for evaluating the functional benefits of half-dose verteporfin PDT in eyes with chronic CSC.Keywords: microperimetry, fixation point, retinal sensitivity, photodynamic therapy, chronic central serous chorioretinopathy
format	article
author	Fujita K Shinoda K Matsumoto CS Imamura Y Tanaka E Mizutani Y Mizota A Yuzawa M
author_facet	Fujita K Shinoda K Matsumoto CS Imamura Y Tanaka E Mizutani Y Mizota A Yuzawa M
author_sort	Fujita K
title	Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
title_short	Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
title_full	Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
title_fullStr	Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
title_full_unstemmed	Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
title_sort	microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/eb8218f287364e40b92ac1de0d3b393b
work_keys_str_mv	AT fujitak microperimetricevaluationofchroniccentralserouschorioretinopathyafterhalfdosephotodynamictherapy AT shinodak microperimetricevaluationofchroniccentralserouschorioretinopathyafterhalfdosephotodynamictherapy AT matsumotocs microperimetricevaluationofchroniccentralserouschorioretinopathyafterhalfdosephotodynamictherapy AT imamuray microperimetricevaluationofchroniccentralserouschorioretinopathyafterhalfdosephotodynamictherapy AT tanakae microperimetricevaluationofchroniccentralserouschorioretinopathyafterhalfdosephotodynamictherapy AT mizutaniy microperimetricevaluationofchroniccentralserouschorioretinopathyafterhalfdosephotodynamictherapy AT mizotaa microperimetricevaluationofchroniccentralserouschorioretinopathyafterhalfdosephotodynamictherapy AT yuzawam microperimetricevaluationofchroniccentralserouschorioretinopathyafterhalfdosephotodynamictherapy
_version_	1718401586466652160

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy

Ejemplares similares